Literature DB >> 8153395

Systemic lupus erythematosus. Antibodies to DNA, DNA-binding proteins, and histones.

W H Reeves1, M Satoh, J Wang, C H Chou, A K Ajmani.   

Abstract

Pathogenic autoantibodies to DNA are frequently associated with autoantibodies to chromatin-associated proteins such as histones or the Ku (p70/p80) antigens. In view of the increasing evidence that autoantibody production is antigen-driven, and because DNA is packaged with proteins in the cell, we suggest that anti-DNA antibodies may arise in response to DNA-protein complexes rather than naked DNA. Recent studies of the specificities of autoantibodies directed against the components of nucleosomes and transcriptional complexes are consistent with this hypothesis. The possible clinical significance of immune recognition of various types of chromatin complexes in autoimmune disease is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8153395

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  14 in total

Review 1.  Laboratory tests in pediatric rheumatology.

Authors:  Manjari Agarwal; Sujata Sawhney
Journal:  Indian J Pediatr       Date:  2010-08-26       Impact factor: 1.967

Review 2.  Anti-DNA antibodies as early predictor for disease exacerbations in SLE. Guideline for treatment?

Authors:  P E Spronk; H Bootsma; C G Kallenberg
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

3.  Autoantibodies in black South Africans with systemic lupus erythematosus: spectrum and clinical associations.

Authors:  M Tikly; S Burgin; P Mohanlal; A Bellingan; J George
Journal:  Clin Rheumatol       Date:  1996-05       Impact factor: 2.980

4.  Autoantibodies in black South Africans with systemic lupus erythematosus: spectrum and clinical associations.

Authors:  M Tikly; S Burgin; P Mohanlal; A Bellingan; J George
Journal:  Clin Rheumatol       Date:  1996-03       Impact factor: 2.980

5.  Anti-subnucleosome reactivities in systemic lupus erythematosus (SLE) patients and their first-degree relatives.

Authors:  C Mohan; F Liu; C Xie; R C Williams
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

6.  Antibody transfection into neurons as a tool to study disease pathogenesis.

Authors:  Joshua N Douglas; Lidia A Gardner; Sangmin Lee; Yoojin Shin; Chassidy J Groover; Michael C Levin
Journal:  J Vis Exp       Date:  2012-09-26       Impact factor: 1.355

7.  Autoantibodies to RNA polymerase II are common in systemic lupus erythematosus and overlap syndrome. Specific recognition of the phosphorylated (IIO) form by a subset of human sera.

Authors:  M Satoh; A K Ajmani; T Ogasawara; J J Langdon; M Hirakata; J Wang; W H Reeves
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

Review 8.  Laboratory evaluation of the inflammatory myopathies.

Authors:  L G Rider; F W Miller
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

Review 9.  Genetic background and environment contribute synergistically to the onset of autoimmune diseases.

Authors:  P Luppi; M R Rossiello; S Faas; M Trucco
Journal:  J Mol Med (Berl)       Date:  1995-08       Impact factor: 4.599

10.  Evaluation of a new automated enzyme fluoroimmunoassay using recombinant plasmid dsDNA for the detection of anti-dsDNA antibodies in SLE.

Authors:  D Villalta; N Bizzaro; D Corazza; R Tozzoli; E Tonutti
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.